Trial · NCT07906613
Ultrasound-Guided Pericapsular Nerve Group Block for Pain Control After Hip Surgery
NCT07906613, Not applicable, Completed, Cumhuriyet University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Ultrasound-Guided Pericapsular Nerve Group Block for Pain Control After Hip Surgery. Trials, record NCT07906613. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07906613
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Ultrasound-Guided Pericapsular Nerve Group Block for Pain Control After Hip Surgery
- NCT number
- NCT07906613
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- Cumhuriyet University
- Conditions
- Morphine Consumption, Postoperative Pain
- Interventions
- Ultrasound-Guided Pericapsular Nerve Group Block with Bupivacaine, Ultrasound-Guided Placebo Injection with Normal Saline
- First posted
- 2026-10-30
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Cumulative Morphine Consumption During the First 24 Hours After Surgery | First 24 hours after surgery | Total intravenous morphine consumption, measured in milligrams, delivered through the patient-controlled analgesia pump during the first 24 hours after surgery. |
| Secondary | Postoperative Pain Intensity Assessed Using the Visual Analog Scale | At 1, 2, 3, 4, 8, 16, and 24 hours after surgery | Postoperative pain intensity was assessed using a 10-cm visual analog scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity. |
| Secondary | Time to First Rescue Analgesia | During the first 24 hours after surgery | Time, measured in hours, from the end of surgery to the first requirement for rescue analgesia. Rescue analgesia was administered when the visual analog scale pain score exceeded 5. |
| Secondary | Participants Requiring Rescue Analgesia | During the first 24 hours after surgery | Number of participants requiring rescue analgesia during the first 24 postoperative hours. Rescue analgesia consisted of intravenous tramadol 100 mg and intravenous paracetamol 1000 mg when the visual analog scale pain score exceeded 5. |
| Secondary | Incidence of Postoperative Nausea | During the first 24 hours after surgery, assessed at 1, 2, 3, 4, 8, 16, and 24 hours | Number of participants experiencing postoperative nausea during the first 24 hours after surgery. |
| Secondary | Incidence of Postoperative Vomiting | During the first 24 hours after surgery, assessed at 1, 2, 3, 4, 8, 16, and 24 hours | Number of participants experiencing postoperative vomiting during the first 24 hours after surgery. |
| Secondary | Incidence of Postoperative Constipation | During the first 24 hours after surgery, assessed at 1, 2, 3, 4, 8, 16, and 24 hours | Number of participants experiencing constipation during the first 24 hours after surgery. |
| Secondary | Postoperative Heart Rate | At 1, 2, 3, 4, 8, 16, and 24 hours after surgery | Heart rate, measured in beats per minute, at each postoperative assessment. |
| Secondary | Postoperative Mean Arterial Pressure | At 1, 2, 3, 4, 8, 16, and 24 hours after surgery | Mean arterial pressure, measured in mmHg, at each postoperative assessment. |
| Secondary | Patient Satisfaction | At 24 hours after surgery | Patient satisfaction was assessed using four ordered categories: poor, fair, good, and very good. Categories toward very good indicate greater satisfaction. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07906613
GET https://conductscience.org/api/trials/v1/NCT07906613/registered